XML Print


1- Asst. Professor, Research Department of Fisheries and Aquaculture, St. Albert’s College (Autonomous), Ernakulam. Kerala , jithupaul007@gmail.com
2- Department of Microbiology, Sree Gokulam Medical College, Trivandrum, Kerala, India.
3- Department of Microbiology, SreeGokulam Medical College, Trivandrum, Kerala, India.
Abstract:   (269 Views)
Aim: The global distribution of Klebsiella pneumoniae that produce carbapenemase has been gradually increasing.This present study aimed to investigate the molecular characterization of carbapenem-resistant Klebsiella pneumoniae isolates from various clinical samples. Materials and Methods: In this study, 401 bacteria of Klebsiella isolates were isolated from various clinical samples according to standard protocol. The twelve carbapenem-resistant genes of Klebsiella pneumoniae isolates were detected using multiplex polymerase chain reaction (PCR). Results: Multiplex polymerase chain reaction (PCR) for identifying Class A β-lactamases producers (KPC), Class B β-lactamases producers (NDM), and Class D β-lactamases producers (OXA-48) were done. It was noted that 10 isolates expressed KPC followed by one isolate expressed NDM and one isolate expressed OXA-48. Conclusion: In the present study conclude that CP-CRK is a major health problem in the coming years and hence it is necessary to take all adequate measures to identify the resistant strains. Continuous monitoring of these resistant mechanisms is required to establish the changes in the prevalence and sensitivity pattern of MDR Klebsiella isolates. Urgent infection control measures coupled with antibiotic stewardship and strengthening of the healthcare infrastructure are to be instituted in our setting to prevent the spread of these Carbapenem-resistant genes of Klebsiella pneumoniae (KPC). Larger multicenter studies are required to thoroughly assess risk variables and historical trends in order to comprehend the dynamics of spread and efficient management strategies.

Full-Text [PDF 385 kb]   (90 Downloads)    
Research Article: Research Article | Subject: Microbiology
Received: 2023/01/12 | Accepted: 2023/04/8

References
1. Sekar R, Srivani S, Amudhan M, Mythreyee M. Carbapenem resistance in a rural part of southern India: Escherichia coli versus Klebsiella spp. The Indian journal of medical research. 2016; 144(5): 781. [View at Publisher] [DOI] [PMID] [Google Scholar]
2. Tamma PD, Opene BN, Gluck A, Chambers KK, Carroll KC, Simner PJ. Comparison of 11 phenotypic assays for accurate detection of carbapenemase-producing Enterobacteriaceae. Journal of clinical microbiology. 2017; 55(4): 1046-55. [View at Publisher] [DOI] [PMID] [Google Scholar]
3. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. The Lancet infectious diseases. 2010; 10(9): 597-602. [View at Publisher] [DOI] [PMID] [Google Scholar]
4. van Duin D, Doi Y. The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence. 2017; 8(4): 460-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
5. Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, et al. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009; 53(12): 5046-54. [View at Publisher] [DOI] [PMID] [Google Scholar]
6. Shrestha B, Tada T, Shimada K, Shrestha S, Ohara H, Pokhrel BM, et al. Emergence of various NDM-type-metallo-β-lactamase-producing Escherichia coli clinical isolates in Nepal. Antimicrobial agents and chemotherapy. 2017; 61(12): 10-128. [View at Publisher] [DOI] [PMID] [Google Scholar]
7. Rahman M, Shukla SK, Prasad KN, Ovejero CM, Pati BK, Tripathi A, et al. Prevalence and molecular characterisation of New Delhi metallo-β-lactamases NDM-1, NDM-5, NDM-6 and NDM-7 in multidrug-resistant Enterobacteriaceae from India. Int J Antimicrob Agents. 2014; 44(1): 30-7. [View at Publisher] [DOI] [PMID] [Google Scholar]
8. Mohanty S, Mittal G, Gaind R. Identification of carbapenemase-mediated resistance among Enterobacteriaceae bloodstream isolates: a molecular study from India. Indian Journal of Medical Microbiology. 2017; 35(3): 421-5. [View at Publisher] [DOI] [PMID] [Google Scholar]
9. Walsh TR, Weeks J, Livermore DM, Toleman MA. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. The Lancet infectious diseases. 2011; 11(5): 355-62. [View at Publisher] [DOI] [PMID] [Google Scholar]
10. Queenan AM, Bush K. Carbapenemases: the versatile β-lactamases. Clinical microbiology reviews. 2007; 20(3): 440-58. [View at Publisher] [DOI] [PMID] [Google Scholar]
11. Nordmann P, Poirel L, Dortet L. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerging infectious diseases. 2012; 18(9): 1503. [View at Publisher] [DOI] [PMID] [Google Scholar]
12. Tijet N, Patel SN, Melano RG. Detection of carbapenemase activity in Enterobacteriaceae: comparison of the carbapenem inactivation method versus the Carba NP test. Journal of Antimicrobial Chemotherapy. 2016; 71(1): 274-6. [View at Publisher] [DOI] [PMID] [Google Scholar]
13. Nordmann P, Poirel L, Dortet L. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerging infectious diseases. 2012; 18(9): 1503. [View at Publisher] [DOI] [PMID] [Google Scholar]
14. Mancini S, Kieffer N, Poirel L, Nordmann P. Evaluation of the RAPIDEC® CARBA NP and β-CARBA® tests for rapid detection of Carbapenemase-producing Enterobacteriaceae. Diagnostic microbiology and infectious disease. 2017; 88(4): 293-7. [View at Publisher] [DOI] [PMID] [Google Scholar]
15. Collee JG, Miles RS, Watt B. Tests for identification of bacteria. Mackie and McCartney practical medical microbiology. 1996;14:131-49. [View at Publisher]
16. Pierce VM, Simner PJ, Lonsway DR, Roe-Carpenter DE, Johnson JK, Brasso WB, et al. Modified carbapenem inactivation method for phenotypic detection of carbapenemase production among Enterobacteriaceae. Journal of clinical microbiology. 2017; 55(8): 2321-33. [View at Publisher] [DOI] [PMID] [Google Scholar]
17. Sekar R, Srivani S, Amudhan M, Mythreyee M. Carbapenem resistance in a rural part of southern India: Escherichia coli versus Klebsiella spp. The Indian journal of medical research. 2016; 144(5): 781. [View at Publisher] [DOI] [PMID] [Google Scholar]
18. Mangayarkarasi V, Anitha K, Raja Rajeswar D, Kalaiselvi. The CTX-M Type ESBL Gene Production by Klebsiella Species in Urinary Tract Infection. International Journal of Current Microbiology and Applied Sciences. 2017; 6(7): 888-94. [View at Publisher] [DOI]
19. Patilaya P, Husori DI, Marhafanny L. Susceptibility of KlebsiellaPneumoniae Isolated from Pus Specimens of Post-Surgery Patients in Medan, Indonesia to Selected Antibiotics. Open Access Maced J Med Sci. 2019; 7(22): 3861-3864. [View at Publisher] [DOI] [PMID] [Google Scholar]
20. Ravichitra KN, Prakash PH, Subbarayudu S, Rao US. Isolation and antibiotics sensitivity of Klebsiellapneumoniae from pus, sputum, and urine samples. Int J CurrMicrobiol App Sci. 2014; 3(3): 115-9. [View at Publisher] [Google Scholar]
21. Ferreira RL, Da Silva BC, Rezende GS, Nakamura-Silva R, Pitondo-Silva A, Campanini EB, et al. High prevalence of multidrug-resistant Klebsiella pneumoniae harboring several virulence and β-lactamase encoding genes in a Brazilian intensive care unit. Frontiers in microbiology. 2019; 9: 3198. [View at Publisher] [DOI] [PMID] [Google Scholar]
22. Bina M, Pournajaf A, Mirkalantari S, Talebi M, Irajian G. Detection of the Klebsiellapneumoniaecarbapenemase (KPC) in K. pneumoniae Isolated from the Clinical Samples by the Phenotypic and Genotypic Methods. Iranian journal of pathology. 2015; 10(3):199. [View at Publisher] [PMID] [Google Scholar]
23. Shanmugam P, Meenakshisundaram J, Jayaraman P. blaKPC gene detection in clinical isolates of carbapenem resistant Enterobacteriaceae in a Tertiary Care Hospital. J ClinDiagn Res. 2013; 7(12):2736-8. [View at Publisher] [DOI] [PMID] [Google Scholar]
24. Shilpakar A, Ansari M, Rai KR, Rai G, Rai SK. Prevalence of multidrug-resistant and extended-spectrum beta-lactamase producing Gram-negative isolates from clinical samples in a tertiary care hospital of Nepal. Trop Med Health. 2021; 49(1): 23. [View at Publisher] [DOI] [PMID] [Google Scholar]
25. Basnyat B, Pokharel P, Dixit S, Giri S. Antibiotic use, its resistance in Nepal and recommendations for action: a situation analysis. J Nepal Health Res Counc. 2015; 13(30): 102-11. [View at Publisher] [PMID] [Google Scholar]
26. Pasteran F, Tijet N, Melano RG, Corso A. Simplified protocol for Carba NP test for enhanced detection of carbapenemase producers directly from bacterial cultures. Journal of clinical microbiology. 2015; 53(12): 3908-11. [View at Publisher] [DOI] [PMID] [Google Scholar]
27. Vivan AC, Rosa JF, Rizek CF, Pelisson M, Costa SF, Hungria M, Kobayashi R, Vespero EC. Molecular characterization of carbapenem-resistant Klebsiella pneumoniae isolates from a university hospital in Brazil. The Journal of Infection in Developing Countries. 2017; 11(05): 379-86. [View at Publisher] [DOI] [PMID] [Google Scholar]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2007 All Rights Reserved | Medical Laboratory Journal

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.